NCT01715324 - Adjuvant Growth Therapy in in Vitro Fertilization | Biotech Hunter

Enrollment

288

Participants

Timeline

Start Date

June 25, 2014

Primary Completion Date

July 31, 2021

Study Completion Date

August 31, 2021

Conditions

Infertility

Interventions

DRUG

Adjuvant Growth Hormon

The treatment group will receive 2.5 mg of Saizen daily via subcutaneous injections, from the beginning of the ovarian reserve stimulation until the day of the ovulation triggering

Trial Locations (1)

H4P 2S4

Clinique Ovo, Montreal